RIFFdWEBPVP8 Xf*>i,E"~@h&Udq=$cgĜx[]o1Ѿ?_~S;-iυw{S]?ڿUI_(RJG}I{$r܎#&ZȲpȃWG&3Nl"uskz~FNe<=QzhԷ}i܍y;& *8 "f;xxSQVrU*.GT#Nz>i%~l;eU|f)#, 6Mn~tM]!tE:sxHR'<%$9)kx$s fZ, ~iI[!JHfXJ$+o#%nABvRևS'䚟V6BeVF=fpkGHGHntgnh2#y40OӔ(k#"!^J0LȇJmi=k5RS.+&:wv?]7//Et6H! ,1+j1ƌP jw7#Y:94!b A>m.&8 +ge.̕m &KF LN*d<ȴA($+ϭigDAp tj}k2KS^ _MއvEq~)x,l٣ڬn8UcpV;| ӷ%*ɼ_뉨ɇЫ#jr0@gm5|Ҷ%նza:@ZL )J+ՙ]CRv`6ӓR9w'yʺ߭32昬RFQjV D>Y OzyLBw=nWpc 5T|M wD`vIчF!_ɎCkyRɉǕN lrq-) C}vV•1b0M+6v<,cw4[H:Kq"҅:6ª@u}OVQv*zByo*zw?L1BA*Xi)NJ$vݙ8/9L(B&b/2bۉ 򎐄%8r lƍW0=(d3XU8]-z4Ұ6:OɯPv,UOeNhAHsDF 6z'O!OV-,_83qV%,ǓP|y$?S'Q~+՟d9Z^*k+-ảN`fY373\ Cb[u)6VT=,]٤,ϲ̻f9M7p3~AآQɴwt98Z'ë@!dDB:$sYwܩ@/*ܚ+4q.k:墟{|M/tSp[[sUS;iPGq ,k6 &﹒NX}vL4_soE<hhψ  e1A&t5iN>pжnHMTo9]'ǘ;HlY;1:~dV`uw=n,ZtV*R7kЍ/{qE8>rAɠ~\p#+ eCl|fˠJ! )!݁bk8 dY_i%&uz*tjƍC:=9lK8",b)QQNs=(S-E; \N& QFY((i Idc Z'd+R1U‰# -eQ(G@Ag͙(G 4N2nT1]{qY]/ؒ!r^֭mP9`|ל~,pQce_ܳ0rnyC 2-۴B|Š}4eĎ. bpO_eژ@u c͕F,#kn(T܏d LjP][MXTg$k, ,o+EC ;"9lnzKZQ<;YBO]j7% JJv`d:PF#xis"&R`M"ySIۇ]_K+[:ڈ.\Ն㗘e&cI_$l= FҐE(c͞lL{۫Ͱ$6]`͛R v)gNiآ;xW%,Q7/?wg4B9XGVfbQKpȥ`O%k+"U(zzXBҶ1MxC9/g>f3쯩>90c8f%on`7PO>MDWi%*#P-] T\_xBŎNэ 0_llj&i#N<.J8|? mq'MIhIȿNkQUO;+qXKE5yqn%,)Ehps@8jo(j|7hT7P 85]?COr=x |!Oq1r53h M#8Zb N%,5@Ô8QH\d.o~'+z/CQL-%rрd=E=9 `&N[C&lRSuD\;Պkɾ3t_N?ײvj\h';^rlתH`lZ/6KSD{59M&vDBpt9.SrfB#B-@.f̆%h,oSΖ4: ʑ(" s@$ڋbm"O(4n89å1yN!Np$^VpG52j̕ke,௿0`,^ɥ[uK/fH9֮G1D# y; yKNO4M[ꒆ9AnmB8š;9O5Je $|_Pzy$c NL]0ERV۝rm3Oq8MnNR'Q2ɱ3}2kFfߓ^5w$^QB{IB4 d!&tMgdj/t+^^4nQ|԰͹i9C HL%wHAh(0QHDK1-XQtF_=cծ8"yUTK_/SB dL@5IĪ;Kؚ# C7ņ*)A%"M7,0KW2#V8#ܶGx`u6_;T~>YIh~#NcƵե J®W:瞝eNhZ7 Y]ɮ b&6 a%Ax@2C`T4PFhi(EIgn!ی՛K;t>^oG!4oG[ La{>?iu#w,j &]X(l/!|va?.8V` >#E-?4a& # T'4|`l֭ڑNW|+9}ߺi?ɤ4LjC>Z'PDd͂LBљ{F:&#Z1z^ ,HDU&1N˾ftTp9 2Uʆӄe^L?34 Ӭ*r4v`X3]ܚ[m΍l7=w\`GBNh\|!O߼ ZX`VW_xi&xRZeKudP^³,ٛTˣq( إFAtj Mr;>>^!w͍SqI?q4߂/󿕦)7:@Q"hdk"Qʩphzx/)2Ȋ} ZtP8ES  _ )ذ*T}<k֒T5 3GѺ=$8G ?! "G)8Cp;~EV 5hl$߈Y,ܗg7,M\ǹw•%} =q 2HXQIfLDŽpߐ 8uw@ᅸ\8f7b9= 1h?ZI"LH+9nOiI n\*!7k^*NhհwM`aNEM֐yI婟rPɳmXX?v/Y&U8L(j i >TMK02lf~i'9b75 G@Oҙeay{OljG>?`H%X'IX?X",+%hX.=ˀ P8k6Ƕh|&7}A~ZΤl#:1%yh!Մ+:|OB*Bz%M}K e\ ^3lSRsWRmo%>]FJ=k6 kW& {N<7p 7g'S-?:Mg Iӟ wRxA